Gritstone bio, Inc.
GRTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $236 | $314 | $1,014 | $149 |
| - Cash | $65 | $55 | $93 | $170 |
| + Debt | $105 | $40 | $26 | $25 |
| Enterprise Value | $275 | $298 | $948 | $4 |
| Revenue | $1 | $9 | $47 | $4 |
| % Growth | -85.6% | -80.2% | 1,057.2% | – |
| Gross Profit | -$6 | -$6 | $32 | -$85 |
| % Margin | -470.3% | -69.3% | 69.2% | -2,095.8% |
| EBITDA | -$127 | -$112 | -$69 | -$99 |
| % Margin | -9,531.4% | -1,207.2% | -147.1% | -2,444.1% |
| Net Income | -$138 | -$113 | -$75 | -$105 |
| % Margin | -10,405% | -1,220.5% | -160.4% | -2,591.3% |
| EPS Diluted | -1.2 | -1.24 | -0.95 | -2.77 |
| % Growth | 3.2% | -30.5% | 65.7% | – |
| Operating Cash Flow | -$122 | -$116 | -$51 | -$89 |
| Capital Expenditures | -$5 | -$6 | -$5 | -$4 |
| Free Cash Flow | -$126 | -$122 | -$56 | -$93 |